Paclitaxel and trastuzumab for breast cancer

Thomas Lehmann, Dominic Solimando, James Waddell

Research output: Contribution to journalArticle

Abstract

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr., President, Oncology Pharmacy Services, Inc., 4201 Wilson Blvd #110-545, Arlington, VA 22203, e-mail: OncRxSvc@comcast.net; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, e-mail: waddfour@charter.net.

Original languageEnglish (US)
Pages (from-to)338-344
Number of pages7
JournalHospital Pharmacy
Volume49
Issue number4
DOIs
StatePublished - Apr 1 2014

Fingerprint

Oncology
Postal Service
Paclitaxel
Pharmacists
Breast Neoplasms
Pharmaceutical Services
Chemotherapy
Poisons
Highway systems
Antineoplastic Agents
Drug Therapy
Neoplasms
Trastuzumab
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmacology
  • Pharmacology (medical)

Cite this

Paclitaxel and trastuzumab for breast cancer. / Lehmann, Thomas; Solimando, Dominic; Waddell, James.

In: Hospital Pharmacy, Vol. 49, No. 4, 01.04.2014, p. 338-344.

Research output: Contribution to journalArticle

Lehmann, Thomas ; Solimando, Dominic ; Waddell, James. / Paclitaxel and trastuzumab for breast cancer. In: Hospital Pharmacy. 2014 ; Vol. 49, No. 4. pp. 338-344.
@article{2b6f79afcc35467bb9053ae8c85abcd4,
title = "Paclitaxel and trastuzumab for breast cancer",
abstract = "The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr., President, Oncology Pharmacy Services, Inc., 4201 Wilson Blvd #110-545, Arlington, VA 22203, e-mail: OncRxSvc@comcast.net; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, e-mail: waddfour@charter.net.",
author = "Thomas Lehmann and Dominic Solimando and James Waddell",
year = "2014",
month = "4",
day = "1",
doi = "10.1310/hpj4904-338",
language = "English (US)",
volume = "49",
pages = "338--344",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Facts and Comparisons",
number = "4",

}

TY - JOUR

T1 - Paclitaxel and trastuzumab for breast cancer

AU - Lehmann, Thomas

AU - Solimando, Dominic

AU - Waddell, James

PY - 2014/4/1

Y1 - 2014/4/1

N2 - The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr., President, Oncology Pharmacy Services, Inc., 4201 Wilson Blvd #110-545, Arlington, VA 22203, e-mail: OncRxSvc@comcast.net; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, e-mail: waddfour@charter.net.

AB - The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr., President, Oncology Pharmacy Services, Inc., 4201 Wilson Blvd #110-545, Arlington, VA 22203, e-mail: OncRxSvc@comcast.net; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, e-mail: waddfour@charter.net.

UR - http://www.scopus.com/inward/record.url?scp=84899021268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899021268&partnerID=8YFLogxK

U2 - 10.1310/hpj4904-338

DO - 10.1310/hpj4904-338

M3 - Article

VL - 49

SP - 338

EP - 344

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

IS - 4

ER -